-
Mark L. Baum, J.D.
Chief Executive Officer, Member, Board of Directors
Mr. Baum is a founder, member of the board of directors and Chief Executive Officer of the company. Read More
-
Andrew R. Boll, CFA, CMA
Chief Financial Officer
Mr. Boll joined Imprimis in December 2011 as a consultant until he was hired as Vice President of Accounting and Public Reporting (Principal Financial and Accounting Officer) of the company in February 2012. Read More
-
John Saharek
Chief Commercial Officer
Mr. Saharek started with Imprimis as Vice President of Commercialization, Ophthalmology in November 2013 until his promotion to Chief Commercial Officer in February 2015. Read More
-
Pramod Sharma
Vice President, Quality
Mr. Sharma has been the Vice President of Quality since August 2016 and oversees the expansion of all Imprimis quality systems in line with the highest pharmaceutical and compounding industry standards. Read More
-
Sanjay Samudre
Vice President, Manufacturing
Mr. Samudre has been the Vice President of Manufacturing at Imprimis since May 2016 where he oversees supply chain and production while adding automation and scalability to many the company’s core compounded formulations. Read More
-
David Moufarrege
Vice President, Technology
Mr. Moufarrege oversees all company technology operations, including technical infrastructure, software development, and integrations. Read More
-
Victor Repkin
Intellectual Property Counsel
Dr. Repkin has served as patent attorney and intellectual property counsel for Imprimis since June 2013. Read More
Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745
Interested in receiving investor news and updates?
Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.